MetLife Investment Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-24,854
| Closed | -$501K | – | 2592 |
|
|
2021
Q3 | $501K | Hold |
24,854
| – | – | ﹤0.01% | 1519 |
|
|
2021
Q2 | $928K | Sell |
24,854
-4,181
| -14% | -$156K | 0.01% | 1211 |
|
|
2021
Q1 | $742K | Hold |
29,035
| – | – | 0.01% | 1294 |
|
|
2020
Q4 | $640K | Hold |
29,035
| – | – | 0.01% | 1358 |
|
|
2020
Q3 | $522K | Hold |
29,035
| – | – | 0.01% | 1346 |
|
|
2020
Q2 | $737K | Buy |
29,035
+6,181
| +27% | +$157K | 0.01% | 1169 |
|
|
2020
Q1 | $420K | Hold |
22,854
| – | – | 0.01% | 1309 |
|
|
2019
Q4 | $503K | Sell |
22,854
-4,933
| -18% | -$109K | 0.01% | 1458 |
|
|
2019
Q3 | $399K | Hold |
27,787
| – | – | ﹤0.01% | 1548 |
|
|
2019
Q2 | $438K | Buy |
27,787
+6,076
| +28% | +$95.7K | ﹤0.01% | 1561 |
|
|
2019
Q1 | $318K | Hold |
21,711
| – | – | ﹤0.01% | 1720 |
|
|
2018
Q4 | $232K | Hold |
21,711
| – | – | ﹤0.01% | 1821 |
|
|
2018
Q3 | $331K | Hold |
21,711
| – | – | ﹤0.01% | 1794 |
|
|
2018
Q2 | $266K | Buy |
+21,711
| New | +$266K | ﹤0.01% | 1778 |
|